Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

38.960
+0.0200.05%
Volume:4.76M
Turnover:184.56M
Market Cap:235.90B
PE:47.76
High:39.580
Open:38.940
Low:38.160
Close:38.940
52wk High:44.220
52wk Low:15.783
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:0.43
T/O Rate:0.08%
Dividend:0.38
Dividend Rate:0.97%
EPS(LYR):0.816
ROE:16.21%
ROA:8.35%
PB:6.86
PE(LYR):47.76
PS:16.16

Loading ...

November 2025 Hong Kong Stock Market Investment Strategy and Top 10 Stock Picks

Stock News
·
Nov 02

Hansoh Pharmaceutical Group (SEHK:3692) Valuation in Focus After Regulatory Progress on Novel RET Inhibitor

Simply Wall St.
·
Nov 01

Hansoh Pharmaceutical Group Stock Climbs 4.2% in Hong Kong

Dow Jones
·
Oct 31

Hansoh Pharmaceutical Group Stock Advances 1.2% in Hong Kong

Dow Jones
·
Oct 24

Hansoh Pharma Gets China Acceptance for Lung Cancer Drug Application

MT Newswires Live
·
Oct 23

Hansoh (3692) Announces NDA Acceptance for HS-10365 Capsules by NMPA

Bulletin Express
·
Oct 23

China NMPA Accepts Hansoh Pharma's NDA for HS-10365 in RET Fusion-Positive NSCLC

Reuters
·
Oct 23

Hansoh Pharmaceutical - China's Nmpa Accepts Nda for Hansoh's Hs-10365 Capsules

THOMSON REUTERS
·
Oct 23

Hansoh Pharmaceutical Group Stock Sheds 1.8% in Hong Kong

Dow Jones
·
Oct 23

Hansoh Pharmaceutical Group Stock Slides 1.4% in Hong Kong

Dow Jones
·
Oct 21

Roche Partnership Could Be a Game Changer for Hansoh Pharmaceutical Group (SEHK:3692)

Simply Wall St.
·
Oct 21

Hansoh Pharma's Roche Deal Could Help Unlock Commercial Potential -- Market Talk

Dow Jones
·
Oct 20

Haitong International: Hansoh Pharma (03692) Licenses CDH17ADC to Roche for Over $1.5 Billion

Stock News
·
Oct 20

Hansoh Pharma Reports Promising Phase 2 Results for HS-20093 in Relapsed or Refractory Sarcomas

Reuters
·
Oct 20

Hansoh Pharma Reports Positive Phase 2 Results for HS-20089 in Platinum-Resistant Ovarian Cancer

Reuters
·
Oct 20

Swiss stocks - Factors to watch on October 17

Reuters
·
Oct 17

HK Movers | Biomedical Stocks Jump Again With TransThera Sciences up 30%

Tiger Newspress
·
Oct 17

China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche

Reuters
·
Oct 17

HANSOH PHARMA (03692) Enters Licensing Agreement with Roche

Stock News
·
Oct 17

Hansoh Pharmaceutical Group Announces License Agreement with Roche for HS20110 Outside Greater China

Reuters
·
Oct 17